MENU
RNXT
AS OF
Dec 12 closing price
Price
$0.96
Change
-$0.03 (-3.03%)
Capitalization
35.18M
108 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
RNXT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

RenovoRx (RNXT) Ownership - Who owns RenovoRx?

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35.18M
P/E Ratio
N/A
Total Cash
10.04M
Projected Growth
N/A
Total Debt
236K
Revenue
928K
Risk (Beta)
1.82
Dividend Yield
N/A
Total Cash/Share
0.27
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price

Fundamentals

RNXT
Capitalization
35.2M
P/E Ratio
N/A
Risk (Beta)
1.82
Dividend Yield
N/A
Total Cash
10M
Total Cash/Share
0.27
Total Debt
236K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
928K
ROE
N/A
Book Value
8.08M
P/B Ratio
4.36
Cash Flow
N/A
Earnings
-0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
5.83
Current Revenue Per Employee
26600.00
Dividends Per Share - Security
N/A
EBITDA
-11.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.08
Revenue To Assets
-104.58
Shares Held By Institutions
10.9M
Shares Outstanding - Current
36.6M
Total Liabilities
3.13M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-23.031
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RNXT
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNXT showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for RNXT
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4546 El Camino Real
Phone
+1 650 284-4433
Employees
8
Web
https://www.renovorx.com